The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Calsada Crispina since 2024.
This trader's CIK number is 1606833.
At the time of last reporting, Calsada Crispina was the Chief Financial Officer of Regulus Therapeutics Inc.. (stock ticker symbol RGLS).
Also see all insider trading activities at Regulus Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RGLS | 0 | $0 | 5,468 | $6,512 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-18 | RGLS | Sale | 5,468 | 1.19 | 6,512 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Calsada Crispina (Chief Financial Officer of Regulus Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.